Skip to main content
    Z

    Zai Lab Ltd (ZLAB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $23.47
    -1.13 (-4.59%)

    Market Cap: $3.07B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Zai Lab Ltd (ZLAB) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Zai Lab are Legend Biotech (LEGN), Xencor (XNCR) and Telix Pharmaceuticals (TLX). By market cap, Zai Lab ranks 6th of the 13 companies on this page; Crispr Therapeutics AG (CRSP) is the largest at $4.10B.

    Peer Comparison

    ZLAB's ROIC of -23.6% is above the peer median of -29.0%, and its revenue growth of -6.8% is below the median of 16.2%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Zai Lab (ZLAB)$3.07BN/A6.0x-44.9%-23.6%-6.8%0.00%
    Legend Biotech Corp (LEGN)$3.39B266.5x2.3x-0.0%N/A32.0%0.00%
    Xencor Inc (XNCR)$2.78BN/A13.5x-58.8%-17.3%454.9%0.00%
    Telix Pharmaceuticals Limited (TLX)$3.14BN/A5.3x3.8%-0.7%22.3%0.00%
    Zenas BioPharma, Inc. Common Stock (ZBIO)$1.90BN/A168.0x0.0%-104.3%-100.0%0.00%
    Ideaya Biosciences Inc (IDYA)$3.08BN/A85.5x0.0%N/A-95.1%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    Maravai Lifesciences Holdings Inc (MRVI)$1.96BN/A5.2x-30.8%-28.3%10.1%0.00%
    Vir Biotechnology Inc (VIR)$1.71BN/A5.4x-61.0%N/A19582.0%0.00%
    Disc Medicine Inc. (IRON)$3.64BN/AN/A0.0%-40.0%0.0%0.00%
    Arcus Biosciences Inc (RCUS)$2.51BN/A21.5x0.0%-75.9%-65.4%0.00%
    Vericel Corp Ord (VCEL)$2.91B89.8x9.1x10.3%N/A26.5%0.00%
    Crispr Therapeutics AG (CRSP)$4.10BN/A155.2x0.0%-20.3%1325.0%0.00%
    Peer median$2.84B178.2x13.5x0.0%-29.0%16.2%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Zai Lab, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Legend Biotech Corp (LEGN)
    Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology...
    LEGN competitors
    Xencor Inc (XNCR)
    Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of cytokine and monoclonal antibody therapies designed...
    XNCR competitors
    Telix Pharmaceuticals Limited (TLX)
    Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic...
    Zenas BioPharma, Inc. Common Stock (ZBIO)
    Zenas BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of transformative immunology-based...
    ZBIO competitors
    Ideaya Biosciences Inc (IDYA)
    IDEAYA Biosciences, Inc., a synthetic precision medicine oncology company focused on lethality...
    IDYA competitors
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    Maravai Lifesciences Holdings Inc (MRVI)
    Maravai LifeSciences Holdings, Inc., a life sciences company, offers products to enable the development of drug therapies, diagnostics, novel vaccines...
    MRVI competitors
    Vir Biotechnology Inc (VIR)
    Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.
    VIR competitors
    Disc Medicine Inc. (IRON)
    Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development...
    IRON competitors
    Arcus Biosciences Inc (RCUS)
    Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States.
    RCUS competitors
    Vericel Corp Ord (VCEL)
    Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures...
    VCEL competitors
    Crispr Therapeutics AG (CRSP)
    CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases.
    CRSP competitors

    Frequently Asked Questions About ZLAB

    Who are Zai Lab's main competitors?

    The companies most similar to Zai Lab include Legend Biotech (LEGN), Xencor (XNCR), Telix Pharmaceuticals (TLX), Zenas BioPharma, Inc. Common Stock (ZBIO) and Ideaya Biosciences (IDYA), listed from the closest match.

    Who is Zai Lab's biggest competitor?

    Crispr Therapeutics AG (CRSP) is the largest of the similar companies at $4.10B; Legend Biotech (LEGN) is the closest match by business profile, size, sector and industry.

    How does ZLAB stock compare with its competitors?

    ZLAB's P/S is 6.0x against a peer median of 13.5x; its net margin is -44.9% against a peer median of 0.0%.

    Which of Zai Lab's competitors pays a higher dividend?

    Zai Lab pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Zai Lab bigger than its competitors?

    No. Zai Lab is 6th by market cap among the 13 companies on this page; the largest is Crispr Therapeutics AG (CRSP) at $4.10B.